improvement. Other Transaction In Year 2018, the company recorded Baht 34.0 million from gain on changes in fair value less costs to sell biological asset, gain on sales deposits from land Baht 22.2 million and
cost to sale of biological assets. Financial Cost Financial cost in Quarter 2/2019 was Baht 8.5 Million decreased by Baht 1.3 Million or 13.1% from Q2/2018 mainly from bank loan repayment in 2018. Net
Transaction In Quarter 2/2018, the company recorded Baht 22.2 million from gain on sales of deposits for land, Baht 3.9 million from gain on changes in fair value less costs to sell biological asset and Baht
and internal control of subsidiaries improvement. Other Transaction In Quarter 3/2018, the company recorded Baht 4.0 million from gain on changes in fair value less costs to sell biological asset and
essential for economic development and sustainability. Applying science to Thailand?s resource abundance and biological diversity will bring about better quality of life and economic sustainable development
in general greater management participation in SGAH to give more support and necessary controls in the weak areas with the increase in the Company’s direct and indirect equity holding in SGAH from
(149.9) (13.3) Other current assets 252.7 203.1 49.6 24.4 Property, plant and equipment 219.1 96.2 122.9 127.8 Equipment for lease 308.7 358.5 (49.8) (13.9) Biological assets 9.9 0.0 9.9 100.0 Other non
payment of subscribed shares as the consideration of the assignment of participation interests in Draugen Field and Gjøa Field in Norway to pay to Shell in accordance with the agreements regarding the
market by this investment. Also, the Company will have in general greater management participation in SGAH to give more support and necessary controls in the weak areas with the increase in the Company’s
Service Agreement with HCDS. The delegation of the Audit Committee to investigate such transaction was resolved by the Board without the participation of directors who have conflict of interest and held no